NK Cell Therapy Market Report 2025 (Global Edition)

Global NK Cell Therapy Market Report 2025 Market Size Split by Therapeutics (NK Cell Therapies, NK Cell Directed Antibodies, Others), by Approaches (Antibody-Dependent Cell-Mediated Cytotoxicity (ADCC...

NK Cell Therapy Market Report Description

We have various report editions of NK Cell Therapy Market, hence please contact our sales team and author directly to obtain/purchase a desired Edition eg, Global Edition, Regional Edition, Country Specific Report Edition, Company Profiles, Forecast Edition, etc. Request for your Free Sample PDF/Online Access.

NK Cell Therapy Market Insights Video

Competitive Landscape of the NK Cell Therapy Market

The NK Cell Therapy marketplace features an aggressive panorama with key players, including Novartis, Bristol-Myers Squibb, and Adaptimmune, along with emerging biotech firms. These groups are focused on developing revolutionary NK cell products and increasing their clinical trials. Collaborations, partnerships, and mergers are common as organizations purpose to enhance their market position and pressure advancements in NK cell treatment plans.

In February 2023, "Quality of life in QUILT 3.032 study: Patients with BCG-unresponsive non-muscle invasive bladder cancer (NMIBC) receiving IL-15RFc superagonist N-803 plus BCG" was presented by Dr. Karim Chamie, Associate Professor of Urology at UCLA, at the ASCO Genitourinary Cancers Symposium (ASCO GU) conference in San Francisco from February 16 to 18. According to ImmunityBio, Inc. (NASDAQ: IBRX), a clinical trial, the Biologics License Application (BLA) for ImmunityBio's N-803 with BCG for the treatment of NMIBC CIS is presently being reviewed by the Food and Drug Administration (FDA). Source: https://www.forcepoint.com/cyber-edu/data-security In July 2023, ImmunityBio, Inc., a clinical-stage immunotherapy company, announced that it has finished funding to boost operating liquidity and support its ongoing business operations. The Company entered into a securities purchase agreement for a registered direct offering with a number of institutional investors. The agreement allowed for the issuance of ImmunityBio common stock as well as warrants to purchase additional shares of the Company's common stock. This transaction is expected to generate gross funds at completion of about USD 50 million before offering-related costs, subject to customary closing conditions. If fully exercised, the warrants can yield additional gross profits of up to USD 60 million. Source: https://immunitybio.com/immunitybio-announces-execution-of-40-million-equity-financing-with-institutional-investors/

Top Companies Market Share in NK Cell Therapy Industry: (In no particular order of Rank)

• Chipscreen Biosciences
• Ltd.
• AltorBioScience Corporation
• Innate Pharma S.A.
• Affimed N.V.
• Bristol-Myers Squibb
• Sorrento Therapeutics Inc.
• NantKwest Inc.
• Takeda Pharmaceutical Company Limited
• NKT Therapeutics
• Inc.
• Confidential Data
• Access The Paid Version
• Data Hidden

*List of Second Tier Companies, List of Third Tier/ Start-up Companies (Inquire with sales executive) Request Any Company Profile for Preview Purpose OR Data Validation!

If any Company(ies) of your interest has/have not been disclosed in the above list then please let us know the same so that we will check the data availability in our database and provide you the confirmation or include it in the final deliverables.

Regional Analysis of the NK Cell Therapy Market

Which Region Dominates the NK Cell Therapy Market in 2024?

According to Cognitive Market Research, North America currently dominates the NK Cell Therapys market, and the region is expected to have significant growth during the projected period. The NK Cell Therapy marketplace in North America is experiencing substantial growth because of growing cancer prevalence, advancements in immunotherapy studies, and robust investment in biotech innovations. Supportive regulatory frameworks and a developing quantity of scientific trials are, in addition, riding the adoption and improvement of NK cellular cures in the place.

Which Region is Expanding at the Fastest CAGR?

Asia-Pacific is expected to make significant gains during the projected period, with the greatest compound annual growth rate (CAGR). The NK Cell Therapy marketplace in the Asia-Pacific location is unexpectedly increasing, fueled by growing most cancer quotes, growing healthcare investments, and improvements in biotechnology. Growing recognition of immunotherapies and supportive government tasks are also contributing to the marketplace's boom, enhancing access to modern NK cell treatment alternatives for patients.

The current report Scope analyzes NK Cell Therapy Market on 5 major region Split (In case you wish to acquire a specific region edition (more granular data) or any country Edition data then please write us on info@cognitivemarketresearch.com

• North America (United States, Canada, Mexico)
• Europe (United Kingdom, France, Germany, Italy, Russia, Spain, Sweden, Denmark, Switzerland, Luxembourg, Rest of Europe)
• Asia Pacific (China, Japan, South Korea, India, Australia, Singapore, Taiwan, South East Asia, Rest of APAC)
• Latin America (Brazil, Argentina, Colombia, Peru, Chile, Rest of South America)
• Middle East (Saudi Arabia, Turkey, UAE, Egypt, Qatar, Rest of Middle East)
• Africa (Nigeria, South Africa, Rest of Africa)

The above graph is for illustrative purposes only.

North America NK Cell Therapy Market Analysis

According to Cognitive Market Research, the global NK Cell Therapy market size was estimated at USD 100.5 Million, out of which North America held the major market share of more than 40% of the global revenue with a market size of USD 40.20 million in 2024 and will grow at a compound annual growth rate (CAGR) of 42.4% from 2024 to 2031.

• According to Cognitive Market Research, the US had a major share in the NK Cell Therapy market with a market size of USD 31.72 million in 2024 and is projected to grow at a CAGR of 42.2% during the forecast period. The U.S. market's rising cancer prevalence.
• The Canada NK Cell Therapy market had a market share of USD 4.82 million in 2024 and is projected to grow at a CAGR of 43.2% during the forecast period. Canada’s advances in immunotherapy.
• The Mexico NK Cell Therapy market is projected to witness growth at a CAGR of 42.9% during the forecast period, with a market size of USD 3.66 million in 2024.

Europe NK Cell Therapy Market Analysis

According to Cognitive Market Research, the global NK Cell Therapy market size was estimated at USD 100.5 Million, out of which Europe held the market share of more than 30% of the global revenue with a market size of USD 30.15 million in 2024 and will grow at a compound annual growth rate (CAGR) of 42.7% from 2024 to 2031.

• The United Kingdom NK Cell Therapy market had a market share of USD 5.07 million in 2024 and is projected to grow at a CAGR of 43.5% during the forecast period. In the UK, NK Cell Therapy sales witness an upswing due to the increased R&D investment.
• The France NK Cell Therapy market is projected to witness growth at a CAGR of 41.9% during the forecast period, with a market size of USD 2.77 million in 2024.
• According to Cognitive Market Research, the German NK Cell Therapy market size was valued at USD 5.97 million in 2024 and is projected to grow at a CAGR of 42.9% during the forecast period. In Germany, NK Cell Therapy surged due to the regulatory support.
• The Italy NK Cell Therapy market is projected to witness growth at a CAGR of 42.1% during the forecast period, with a market size of USD 2.59 million in 2024.
• The Russia NK Cell Therapy market is projected to witness growth at a CAGR of 41.7% during the forecast period, with a market size of USD 4.67 million in 2024.
• The Spain NK Cell Therapy market is projected to witness growth at a CAGR of 41.8% during the forecast period with a market size of USD 2.47 million in 2024
• The Luxembourg NK Cell Therapy market is projected to witness growth at a CAGR of 42.8% during the forecast period, with a market size of USD 0.93 million in 2024.
• The Portugal NK Cell Therapy market is projected to witness growth at a CAGR of 42.5% during the forecast period, with a market size of USD 0.63 million in 2024.
• The Greece NK Cell Therapy market is projected to witness growth at a CAGR of 43.0% during the forecast period, with a market size of USD 0.36 million in 2024.
• The Rest of Europe's NK Cell Therapy market is projected to witness growth at a CAGR of 41.4% during the forecast period, with a market size of USD 4.67 million in 2024.

Asia Pacific NK Cell Therapy Market Analysis

According to Cognitive Market Research, the global NK Cell Therapy market size was estimated at USD 100.5 Million, out of which Asia Pacific held the market share of around 23% of the global revenue with a market size of USD 23.12 million in 2024 and will grow at a compound annual growth rate (CAGR) of 46.2% from 2024 to 2031.

• According to Cognitive Market Research, the China NK Cell Therapy market size was valued at USD 10.40 million in 2024 and is projected to grow at a CAGR of 45.7% during the forecast period. NK Cell Therapy surged in China due to expanding clinical trials.
• The Japan NK Cell Therapy market is projected to witness growth at a CAGR of 44.7% during the forecast period, with a market size of USD 3.19 million in 2024.
• The India NK Cell Therapy market had a market share of USD 2.77 million in 2024 and is projected to grow at a CAGR of 48.0% during the forecast period. India's growing awareness.
• The South Korean NK Cell Therapy market is projected to witness growth at a CAGR of 45.3% during the forecast period, with a market size of USD 2.31 million in 2024.
• The Australian NK Cell Therapy market is projected to witness growth at a CAGR of 45.9% during the forecast period, with a market size of USD 1.20 million in 2024.
• The South East Asia NK Cell Therapy market is projected to witness growth at a CAGR of 47.2% during the forecast period, with a market size of USD 1.59 million in 2024.
• The Rest of Asia Pacific NK Cell Therapy market is projected to witness growth at a CAGR of 46.0% during the forecast period, with a market size of USD 1.64 million in 2024.

South America NK Cell Therapy Market Analysis

According to Cognitive Market Research, the global NK Cell Therapy market size was estimated at USD 100.5 Million, out of which the Latin America held the market share of around 5% of the global revenue with a market size of USD 5.03 million in 2024 and will grow at a compound annual growth rate (CAGR) of 43.6% from 2024 to 2031.

• According to Cognitive Market Research, the Brazil NK Cell Therapy market size was valued at USD 2.15 million in 2024 and is projected to grow at a CAGR of 44.2% during the forecast period. NK Cell Therapys flourished in Brazil due to technological innovations.
• Argentina's NK Cell Therapy market had a market share of USD 0.84 million in 2024 and is projected to grow at a CAGR of 44.5% during the forecast period. Argentina's enhanced manufacturing processes.
• Colombia NK Cell Therapy market is projected to witness growth at a CAGR of 43.4% during the forecast period, with a market size of USD 0.45 million in 2024.
• Peru NK Cell Therapy market is projected to witness growth at a CAGR of 43.8% during the forecast period, with a market size of USD 0.41 million in 2024.
• Chile NK Cell Therapy market is projected to witness growth at a CAGR of 43.9% during the forecast period, with a market size of USD 0.36 million in 2024.
• The Rest of Latin America's NK Cell Therapy market is projected to witness growth at a CAGR of 42.7% during the forecast period, with a market size of USD 0.81 million in 2024.

Middle East NK Cell Therapy Market Analysis

According to Cognitive Market Research, the global NK Cell Therapy market size was estimated at USD 100.5 Million, out of which the Middle East and Africa held the major market share of around 2% of the global revenue with a market size of USD 2.01 million in 2024 and will grow at a compound annual growth rate (CAGR) of 43.9% from 2024 to 2031..

• The GCC Countries NK Cell Therapy market is projected to witness growth at a CAGR of 44.7% during the forecast period, with a market size of USD 0.86 million in 2024. NK Cell Therapy sales flourish due to the collaborations and partnerships.
• The Egypt NK Cell Therapy market is projected to witness growth at a CAGR of 44.2% during the forecast period, with a market size of USD 0.21 million in 2024.
• The South Africa NK Cell Therapy market is projected to witness growth at a CAGR of 44.9% during the forecast period, with a market size of USD 0.32 million in 2024. NK Cell Therapy sales flourished in South Africa due to improved patient outcomes.
• The Turkey NK Cell Therapy market is projected to witness growth at a CAGR of 43.4% during the forecast period, with a market size of USD 0.17 million in 2024.
• The Nigeria NK Cell Therapy market is projected to witness growth at a CAGR of 43.0% during the forecast period, with a market size of USD 0.21 million in 2024.
• The Rest of the MEA NK Cell Therapy market is projected to witness growth at a CAGR of 42.9% during the forecast period, with a market size of USD 0.24 million in 2024.

NK Cell Therapy Market Analysis

How are Segments Performing in the Global NK Cell Therapy Market?

NK Cell Therapy Market Therapeutics Segment Analysis

According to Cognitive Market Research, NK Cell Therapies are likely to dominate the NK Cell Therapy Market over the forecast period. NK mobile treatment plans are riding the growth of the NK cell therapy marketplace with the aid of presenting progressive treatment alternatives for various cancers. Their capability to harness the immune machine for focused motion in opposition to tumors is gaining popularity, main to extended medical trials, investments, and collaborations geared toward advancing this promising remedy.

The NK Cell Directed Antibodies is the fastest-growing segment in the NK Cell Therapy Market. NK cellular-directed antibodies are significantly contributing to the growth of the NK cell therapy market by enhancing the specificity and effectiveness of treatments. These antibodies improve NK cell activation and concentrate on tumor cells, main to better healing effects and elevated hobby from researchers and investors in developing superior immunotherapies.

The above Chart is for representative purposes and does not depict actual sale statistics. Access/Request the quantitative data to understand the trends and dominating segment of NK Cell Therapy Industry. Request a Free Sample PDF!

NK Cell Therapy Market Approaches Segment Analysis

According to Cognitive Market Research, the Antibody-Dependent Cell-Mediated Cytotoxicity (ADCC) segment holds the largest share of the market. Antibody-dependent cell-mediated Cytotoxicity (ADCC) is propelling the NK Cell Therapy marketplace by enhancing the capacity of NK cells to goal and break most cancer cells. By leveraging antibodies to direct NK cellular activity, ADCC improves therapeutic efficacy, main to extended scientific interest and development of combination cures in cancer treatment.

In the NK Cell Therapy Market, the Bispecific Antibodies has been expanding at a rapid pace. Bispecific antibodies are driving an increase inside the NK Cell Therapy market by using simultaneously enticing NK cells and tumor cells, enhancing anti-tumor pastime. This revolutionary method improves the precision and effectiveness of remedies, main to multiplied clinical trials and investments, in the end advancing the development of targeted immunotherapies for people living with cancer.

The above Graph is for representation purposes only. This chart does not depict actual Market share.

NK Cell Therapy Application Segment Analysis

NK Cell Therapy Market Application Segment Analysis

According to Cognitive Market Research, Cancer Immunoproliferative Disorders segment holds the largest market share. Cancer immunoproliferative disorders are fueling the NK Cell Therapy marketplace's increase as those situations frequently require revolutionary remedy strategies. NK cell therapies offer a targeted technique to combat these problems through enhancing immune responses towards malignant cells, leading to accelerated studies consciousness, medical trials, and potential healing options for affected patients.

In the NK Cell Therapy market, the rapidly growing sector is Acute Infectious Diseases. Acute infectious illnesses are contributing to the increase of the NK Cell Therapy marketplace by means of highlighting the significance of immune machine modulation. NK mobile healing procedures display promise in targeting viral infections and enhancing immune responses, main to multiplied research and scientific hobbies in their software for treating numerous acute infectious illnesses.

• Cancer Immunoproliferative Disorders
• Acute Infectious Diseases
• Gastrointestinal Diseases
• Others

NK Cell Therapy End User Segment Analysis

NK Cell Therapy Market End User Segment Analysis

According to Cognitive Market Research, the Research & Academic Institutes segment dominates the market. Research and educational institutes are driving the boom of the NK Cell Therapy marketplace through significant research and scientific trials. Their recognition of know-how of NK cellular biology and growing novel healing techniques fosters innovation and collaboration, main to improvements in NK cell treatments and growing their potential applications in cancer remedy.

Hospitals is projected to be the fastest-growing segment in the NK Cell Therapy market. Hospitals are a key driving force of the NK Cell Therapy marketplace's growth, as they implement progressive treatment alternatives for people living with cancer. Increasing adoption of NK cell remedies in clinical settings, coupled with better infrastructure and professional personnel, helps patients get entry to superior immunotherapy, significantly contributing to market enlargement.

• Research & Academic Institutes
• Hospitals
• Specialty Clinics

Author's Detail

Anushka Gore

Research Associate at Cognitive Market Research

LinkedIn

Profile

Anushka Gore is a seasoned market researcher specializing in the dynamic landscape of the Pharmaceutical industry. With a keen analytical mind and a deep passion for healthcare advancements, she has dedicated herself unraveling the intricate market trends and consumer behaviors that shape the future of medical technologies and services.

Author's Conclusion